BPA Call 36C25723A0025-36C25723N0398
Award Date 6/5/23
Potential Completion Date 6/4/24
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Temple, TX 76504, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $701,268 firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Exact Sciences Corporation for Oncotype DX genetic testing services. The contract has an ultimate completion date of August 17, 2026. Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, is a for-profit medical technology company that specializes in advanced diagnostic testing services...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Exact Sciences Corporation, Exact Sciences Laboratories, LLC Division, for Oncotype DX testing services. The contract has an ultimate completion date of March 16, 2026 and a ceiling value of $10,442.96. The award is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. No set-aside designation...
- This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 (VISN 15) to Exact Sciences Corporation. The contract is for Oncotype DX testing services to be provided at the Wichita, Kansas location. The total ceiling value of the contract is $17,769.92 with a period of performance through March 15, 2026. Exact Sciences Corporation is the prime contractor and developer of the Oncotype DX cancer testing...
- This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company, for the provision of genomic testing services, primarily the Oncotype DX gene expression profiling test, to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The contract, valued at $76,047.69, is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contract has an...
- This is a $55,263.36 firm fixed price delivery order awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs (VA) to Exact Sciences Corp for the Oncotype DX Breast Cancer Assay testing service. The contract is part of the VA's Medical Laboratory Testing and Analysis Services master contract, which is a General Services Administration (GSA) Federal Supply Schedule contract. The contract has an ultimate completion date of September 30, 2025 and does not have a...
- This is a firm fixed price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA), to Exact Sciences Corp for Oncotype DX breast cancer testing services. The contract has a ceiling value of $6,907.92 and a period of performance ending on July 31, 2024. Exact Sciences Corp is a prime contractor that has previously provided cancer testing and diagnostic services to various federal agencies, including the VA, Defense...
- This federal contract award to Exact Sciences Corporation, a for-profit medical technology company, is for the provision of Oncotype DX testing services. The contract, valued at $701,268.00, is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract has an ultimate completion date of August 17, 2025. No set-aside...
- This is a firm fixed price delivery order for Oncotype DX testing services awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 8 to Exact Sciences Corp, Exact Sciences Laboratories, LLC Division. The award has a potential value of $385,859.34 and a completion date of March 31, 2022. The contract was placed under the Medical Laboratory Testing and Analysis Services Multiple Award Schedule (FSS-621-II) contract. No...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs to Exact Sciences Corp, Exact Sciences Laboratories, LLC Division. The contract, valued at $143,820.00, is for the provision of genomic health genetic testing services to VISN 19 for an option year 4 order. The contract is associated with Exact Sciences' existing Multiple Award Schedule contract for Medical Laboratory...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Exact Sciences Corp for the provision of Oncotype DX genetic testing services for breast cancer patients. The contract was awarded under Exact Sciences' GSA Federal Supply Schedule (FSS-621-II) for Medical Laboratory Testing and Analysis Services. The contract has a potential value of $169,244.04 and runs through September 30, 2022. No set-aside designation was...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70053-36C25723A0025Blanket Purchase Agreement
- 36C25723A0025-36C25723N0398BPA Call
This is a $31,085.64 firm fixed price Blanket Purchase Agreement (BPA) contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Veterans Health Administration (VHA) to Exact Sciences Corp for the provision of its Oncotype DX cancer diagnostic test services. The contract has an ultimate completion date of June 4, 2024 and utilizes Exact Sciences' Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. No set-aside designation was used. Exact Sciences Corp is the prime contractor and has previously provided similar cancer testing and diagnostic services to various federal agencies through both prime and subcontractor relationships.
Generated 8/30/24, 6:57 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($21k) | 8/29/24 | |
| Not listed | Not listed | $52.2k | 6/1/23 |